Perceptive Advisors LLC Galera Therapeutics, Inc. Call Options Transaction History
Perceptive Advisors LLC
- $3.83 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding GRTX
# of Institutions
2Shares Held
909KCall Options Held
0Put Options Held
0About Galera Therapeutics, Inc.
- Ticker GRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,821,600
- Market Cap $1.07M
- Description
- Galera Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the transformation of radiotherapy in cancer. The company's lead product candidate is avasopasem manganese (GC4419), a small molecule superoxide dismutase mimetic, which has completed Phase III clinical tria...